LifeSci Advisors is a Biotech Investor Relations consultancy that provides equity research to clients in medical life-sciences. LifeSci Advisors is a Pharmaceutical Investor Relations consultancy that provides equity research to clients in medical life-sciences. LifeSci Advisors is an Equity Research consultancy that provides equity research to clients in medical life-sciences. LifeSci Advisors is a Corporate Communications consultancy that provides equity research to clients in medical life-sciences. LifeSci Advisors is a Biotechnology consultancy that provides equity research to clients in medical life-sciences. LifeSci Advisors is a Biotech Investor Relations consultancy that provides equity research to clients in medical life sciences. LifeSci Advisors is a Pharmaceutical Investor Relations consultancy that provides equity research to clients in medical life sciences. LifeSci Advisors is an Investor Relations consultancy that provides equity research to clients in Healthcare LifeSci Advisors is an Equity Research consultancy that provides equity research to clients in Pharmaceuticals. LifeSci Advisors is a Corporate Communications consultancy that provides equity research to clients in Medical Devices. LifeSci Advisors is a Healthcare Investor consultancy that provides equity research to clients in Medical Devices. LifeSci Advisors is a Pharmaceutical Investor consultancy that provides equity research to clients in Medical Devices.

Web developed by Bolinger web design

Our Distribution

Our Services LifeSci

Our Approach

Our approach is simple – to effectively communicate each client’s unique value proposition, building momentum for the investment. We begin with deep due diligence, essentially partnering with each client to gain an unparalleled level of understanding. Armed with this information, we are able to develop strategic recommendations, specifically tailored to help each client achieve their corporate goals. This “Client as Partner” approach sets us apart and helps us eclipse the competition.

 

Advisory
Investor Relations and Corporate Communications
Equity Research


Click to See Service Description
Advisory

LifeSci Advisors is a full-service consulting agency for companies in the life sciences, medical technology, and healthcare services. Our veteran team has strong relationships with leaders in the healthcare investment banking, business development, and clinical expert communities. In addition to facilitating specific introductions, we can provide detailed market research to our clients, including end-user surveys.

R&D Strategy
  • 360 review of existing assets and technologies
  • Physician surveys and one on one interviews to gain market insights
  • Access to proprietary network of 50,000+ experts in 20 countries, including scientists, physicians and former FDA advisory committee members
  • Strategies and recommendations to:
    • Prioritize opportunities based on core technologies
    • Optimize in-house utilization of assets
    • Explore sale/licensing of non-strategic assets
Business Development
  • Identify and evaluate products and technologies for in-licensing or out-licensing
  • Identify international licensing opportunities (geographies including Europe and Asia)
  • Assess market opportunity and competitive landscape for new or existing products
  • Review of literature, medical conference presentations, physician interviews
  • Preparation of diligence package for product in-licensing/out-licensing
  • Prepare marketing materials for use in business development
  • Scientific white papers, scientific and business presentations
  • Asset valuation analysis/product NPV, valuation of royalty streams
  • Preparation of models

Investor Relations and Corporate Communications

As a communications consultancy, LifeSci Advisors offers strategic advice to companies in the life sciences, medical technology, and health services, as well as to advisory and investment firms focusing on these industries. We provide our clients with company-specific and situation-specific IR strategy and planning, which encompasses investment theme positioning and development as well as enhancing relationships with institutional investors. We work with senior management to develop capital markets strategies and communications planning around major news flow and events, including medical and investor conferences.

Corporate and Investor Communication Services
  • Investor presentations, website design, programming and SEO, annual reports, 10k wraps, proxy statements and other year-end filing statements
  • Development of style guidelines, logo design, trade advertising and brand strategy
  • Preparation of diligence package for M&A and private placements
  • Assistance in deal marketing; preparation of research package
  • Capital structure advice
Press Release Drafting/Editing and Distribution
  • Our team regularly works with clients to draft/edit/review press releases
  • We have negotiated bulk, low-cost release distribution rates with major wire services
    • We offer US national distribution, which blankets the entire US, hits all the major financials, and has an industry-specific focus
    • Complimentary search engine optimization (SEO)
    • Unlimited word count
    • Complimentary tracking report
    • We provide the option to distribute the release in other countries
    • We also offer the ability to directly distribute releases (via email) to up to 20K journalists
    • Capacity to distribute earnings release and EDGAR filings too

Equity Research

LifeSci Advisors provides equity research to companies specializing in pharmaceutical discovery and development, drug delivery, medical technology, and diagnostics. Our team of equity research analysts understands investors’ need for unique insight to support an educated investment decision. Led by Wall Street veteran Andrew McDonald, our seasoned analysts meticulously research fundamentals, focusing on corporate and scientific milestones, to produce thoughtful, objective and comprehensive evaluations of each company’s investment thesis. We stay up to date and communicate the latest developments in each client’s universe. This model has been embraced by the financial community as the logical evolution of sell-side research.



Contact Us   |   About Us   |   Privacy Policy   |   Disclaimer  |   Careers

©2014 LifeSci Advisors, LLC. All Rights Reserved.

email


Web developed by Bolinger web design